CJC-1295 + Ipamorelin 18mg
GH Stack

CJC-1295 + Ipamorelin 18mg

Pulsatile GH release — recovery and lean tissue.

Pre-filled pen with 9mg CJC-1295 (No DAC) + 9mg Ipamorelin for natural GH pulse stacking.

R1200
per vial
Ask a specialist
  • 3rd-party verified
  • Cold-chain shipping
  • Discreet packaging
  • 99.8% purity

What it is

A combination GHRH analogue (CJC-1295 No DAC) and selective ghrelin mimetic (Ipamorelin) that amplifies natural growth hormone pulses.

Key benefits

  • Increased GH and IGF-1 output
  • Improved sleep depth
  • Lean tissue and recovery support
  • Minimal cortisol/prolactin impact

How it works

CJC-1295 extends GHRH signalling while Ipamorelin selectively triggers the ghrelin receptor — together producing a clean, pulsatile GH release.

Who it's best for

  • Recovery
  • Body recomposition
  • Sleep quality

Suggested protocol

Typical research dosing: 100–300mcg of each, 1–2x daily, 5 days on / 2 off.

Administration guide

Subcutaneous via the pre-filled pen, ideally pre-bed on an empty stomach.

Storage instructions

Refrigerate at 2–8 °C. Protect from light.

Frequently asked questions

How quickly will I notice results from CJC-1295 + Ipamorelin?

Most users report measurable changes within 2–4 weeks of consistent use. Full results typically emerge across an 8–12 week protocol.

Can I stack this with other Peak Protocol products?

Yes. Our compounds are designed to be modular. Pair with complementary stacks from Recovery, Longevity, or Metabolic collections — our specialists can recommend a structure.

Is this third-party tested?

Every batch ships with a Certificate of Analysis verifying purity above 99% from an independent ISO-accredited lab.

What is the return policy?

Unopened, temperature-intact vials may be returned within 14 days. Opened compounds are non-returnable for safety reasons.

Important disclaimer. All Peak Protocol compounds are intended strictly for laboratory research and educational purposes. They are not approved by the FDA for human consumption, treatment, or therapeutic use. Statements have not been evaluated by the FDA. Consult a qualified medical professional before initiating any protocol.
CJC-1295 + Ipamorelin 18mg
R1200